Login

Global Biotech Firm Enters Next Stage of Work on $700 Million New Jersey Manufacturing Facility

BeiGene Expands Footprint in Garden State With R&D Flagship
BeiGene is making progress on its 400,000-square-foot manufacturing and R&D center in Hopewell, New Jersey. (BeiGene)
BeiGene is making progress on its 400,000-square-foot manufacturing and R&D center in Hopewell, New Jersey. (BeiGene)
CoStar News
March 22, 2023 | 10:59 P.M.

A global biotech company is entering the next phase of its construction of a $700 million pharmaceutical manufacturing-and-research flagship facility it's building in New Jersey.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE